FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Hydralazine Hydrochloride Injection
Status: Resolved
»Duration of Shortage: 09/08/2020 - 06/29/2021
»Therapeutic Categories: Cardiovascular

Expand all

Akorn Pharmaceuticals (Revised 06/29/2021)

Company Contact Information:
800-932-5676

Presentation
  • 20 mg/mL, 1mL single dose vial (box of 10) (NDC 17478-934-01)
  • 20 mg/mL, 1mL single dose vial (box of 25) (NDC 17478-934-15)
Note:
  • N/A

American Regent/Luitpold (Revised 06/29/2021)

Company Contact Information:
800-645-1706

Presentation
  • 20mg/ml SDV ( NDC 0517 - 0901-25 )
Note:
  • Available

Fresenius Kabi USA, LLC (Revised 06/29/2021)

Company Contact Information:
888-386-1300

Presentation
  • 20 mg per mL, SDV (NDC 63323-614-01)
Note:
  • Available

Mylan Institutional, a Viatris company (Revised 06/29/2021)

Company Contact Information:
800-796-9526

Presentation
  • 20 mg / 1 ml] 25PK (NDC 67457-291-01)
Note:
  • N/A

X-GEN Pharmaceuticals, Inc. (Revised 06/29/2021)

Company Contact Information:
866-390-4411

Presentation
  • 20 mg/mL per vial (NDC 39822-0500-4)
Note:
  • N/A

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English